SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12451209.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors describe an Alberta family with levodopa-responsive parkinsonism without cerebellar abnormalities. Genetic testing showed expanded repeats for SCA-2; other mutations for parkinsonism were excluded. The expanded allele shows interruption of the CAG repeat with CAA. PET in two affected members showed reduced fluorodopa uptake in striatum and normal raclopride binding. Families with autosomal dominant, levodopa-responsive parkinsonism should be tested for the SCA-2 mutation.
Medical subject headings
- Parkinson Disease
- Spinocerebellar Ataxias